This suggests that once the complex is delivered to the TME by FcRn- or GP60-based shuttling of receptor-bound albumin across the tumor endothelium, the FHAB : HSA complex is retained in that space by binding to SPARC in a dynamic equilibrium with slow release (17). This evidence concerns the gene SPARC and neoplasm.